adagrasib,sotorasib
mirati therapeutics,amgen
['adagrasib', 'lung', 'sotorasib']
co-occurring mutations in three tumor suppressor genes are linked with poor clinical outcomes in patients with kras g12c-mutant non-small cell lung cancer treated with kras g12c inhibitors adagrasib or sotorasib, shared at #aacr23 today. more: 
MD Anderson is a global leader in cancer care, research, education and training, and prevention. Appointments available: 1-877-632-6789